AbbVie Must Detail Efforts To Kneecap Humira Biosimilars

Published: 8/02/2019
AbbVie Must Detail Efforts To Kneecap Humira Biosimilars
Source: WWW.LAW360.COM

AbbVie Inc. has thrown "wrenches into the gears" of high-stakes patent litigation over its hugely popular immunosuppressant Humira, a Delaware magistrate judge said Friday, ordering the drugmaker to swiftly detail any efforts to cripple biosimilar competition.

Read more
Related news
Comment
FACEBOOK